NAD and Its Implications #peptides

About this video

Seeds discusses NAD and argues the more efficient strategy is supporting the body’s own salvage pathway for recycling NAD rather than simply supplying large amounts directly. He questions whether directly administered NAD reaches target cells in the way marketers imply, noting it may be converted and redistributed through the liver, with cells deciding what to do with the resulting material. His main caution is about demand and risk: Seeds claims senescent cells, long-lived immune cells, and, in his words, cancer cells could also draw on that supply. The takeaway is risk-first thinking — consider who else might use a therapy before assuming only healthy cells benefit.

Key takeaways

• Supporting endogenous recycling may be more efficient than direct supply, Seeds argues
• Trace where a molecule actually goes, not where marketing says it goes
• Seeds warns that undesirable cells could also benefit from increased NAD availability
• Every intervention needs a dangers check before a benefits claim

Episode details: published April 26, 2026 · 274 views · 1:51 long. Summary written by Self Growth Videos from the episode itself. The peptide and cellular-medicine concepts described are Dr. William Seeds’s, presented for education — not medical advice. Consult a qualified professional before changing your own health practices. Disclosure: the SSRP Institute sells clinician certification in peptide therapy.

← Previous: A New Era of Medicine #peptides · Next: Gut Health As A Priority #peptides #podcast #rehabtech #health →

All Dr. William Seeds videos · Dr. William Seeds profile · SSRP Institute (official site)